Preferred Label : goserelin;
MeSH definition : A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used
in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic
breast cancer.;
MeSH hyponym : goserelin acetate; ICI-118630; zoladex; ICI 118630; ICI118630; Acetate, Goserelin;
MeSH CAS label : luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-10-deglycinamide-,
2-(aminocarbonyl)hydrazide;
MeSH Related Number : 65807-02-5 (Goserelin);
Registry Number MeSH : 65807-02-5;
Wikipedia link : https://en.wikipedia.org/wiki/Goserelin;
Is substance : O;
UNII : 0F65R8P09N;
InChIKey : BLCLNMBMMGCOAS-URPVMXJPSA-N;
Origin ID : D017273;
UMLS CUI : C0120107;
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used
in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic
breast cancer.
http://www.has-sante.fr/portail/jcms/c_2672233/fr/zoladex
2016
false
France
French
goserelin
drug implants
injections, subcutaneous
antineoplastic agents, hormonal
insurance, health, reimbursement
prostatic neoplasms
neoplasm metastasis
breast neoplasms
neoplasms, hormone-dependent
chemotherapy, adjuvant
goserelin
treatment outcome
evaluation of the transparency committee
---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1075
2016
false
false
false
false
Canada
French
critical appraisal or critical reading
antineoplastic combined chemotherapy protocols
ovary
infertility, female
menopause, premature
gonadotropin-releasing hormone
clinical trials, phase iii as topic
breast neoplasms
chemotherapy, adjuvant
goserelin
---